Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1134236

Cover Image

PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1134236

Global Bone & Joint Health Supplements Market, By Type, By Distribution channels, By Form, By Target consumers, By Region Trend Analysis, Competitive Market Share & Forecast, 2018-2028

PUBLISHED:
PAGES: 114 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4450
Unprintable PDF (Group License)
USD 5550
PDF (Enterprise License)
USD 7850

Add to Cart

Global Bone & Joint Health Supplements Market to Grow at a CAGR of 9.2%, during Forecast Period

Global Bone & Joint Health Supplements Market is thriving owing to the rising awareness of micronutrient inadequacies, rising access to supplements, availability of multiple products, and rising numbers of distribution channels.

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Global Bone & Joint Health Supplements Market was worth USD 10.31 billion in the year 2021. The market is projected to grow at a CAGR of 9.2%, earning revenues of around USD 18.83 billion by the end of 2028. The key driver for the growth of the Global Bone & Joint Health Supplements Market is the aging population's increased desire for dietary supplements. Throughout the anticipated period, it is estimated that the market for supplements for bone and joint health would have significant revenue growth due to the aging baby boomer population and the rise in lifestyle disorders. Moreover, increasing consumer interest in active living, rising disposable income, and expanding health consciousness are further significant drivers of the sector. However, high R&D investments and the high cost of clinical trials hinder market growth.

Growing Consumer Awareness of Micronutrient Deficiencies

Rising consumer knowledge of nutritional deficiencies' prevalence and dangers. Additionally, as more people become aware of how nutritional deficiencies can be remedied by supplementation, the demand for products that support bone and joint health will rise, further boosting the market growth. More people are selecting healthier supplements because nutrition and health are directly intertwined. Middle-class incomes are increasing in several regions of Asia, Latin America, and Africa, enabling consumers to spend more on dietary, nutritional, and food supplements. This results in offering lucrative opportunities for the Global Bone & Joint Health Supplements Market during the forecast period (2022-2028).

Aging Population Supports Market Growth

The elderly population is focusing on adjusting to supplements that are specifically tailored to their needs to maintain their good health and quality of life. As people age, they go through several changes, including psychological, physiological, and social ones that affect how they eat. The older population increasingly relies on individualized dietary regimens and routine meal selections. To maintain their general health, the aging populations of many countries have increased the demand for age-friendly dietary options with improved nutritional value.

Challenge: Regulatory Influence

Numerous changes in the industry are being brought about by the general shift in consumer trends. Regulations and requirements relating to nutrition obtained from dietary supplements are evolving. These laws were created in response to evolving nutritional care standards. The FDA and FSSAI have introduced some of these rules. These rules apply to probiotic and prebiotic foods as well as dietary supplements and foods for special diets. The Food and Nutrition Board of the National Academy of Medicine has established recommended dietary allowances and safe upper limits. The quality, efficacy, and safety of supplements for bone and joint health face regulatory obstacles. Regulations governing supplements including vitamins and omega fatty acids sold in South Africa ensure that each product is registered with and approved by SAHPRA. The market as a whole may face serious obstacles as a result of these new restrictions.

Segmental Coverage

Global Bone & Joint Health Supplements Market - By Form

Based on the form, the Global Bone & Joint Health Supplements Market is segmented into Tablets, Capsules, Liquid, Powder, and Others. During the forecast period, the tablet segment is anticipated to develop at the greatest CAGR. Due to the simple availability of varied dosage patterns, simple packaging, storage, and cost-effectiveness, the tablet form of bone and joint health supplements is frequently used. Tablet-based supplements for bone and joint health are ingested because they contain a variety of nutrients, including vitamins and omega-3 fatty acids. Due to their long shelf lives compared to other forms of nutritional supplements, tablets are also favored. The benefits of compressed tablets are their general stability and wide range of sizes and shapes. As a result, it is simple to mix a variety of nutritious supplements into tablet form. Because of this, compresses tablets are popular.

Impact of COVID-19 on Global Bone & Joint Health Supplements Market

To avoid COVID-19, international health agencies such as the World Health Organization (WHO) advise consumers to boost their immune systems. Nutraceuticals with immune-boosting qualities, such as collagen, vitamins, and calcium, are predicted to gain popularity. As a result of the COVID-19 epidemic, the population is embracing social distance and following the trend of working from home or remaining at home, causing consumers to modify their regular habits, such as becoming more health concerned, resulting in an unprecedented level of supplement demand. Consumers' need for self-care is fueling the growth of bone and joint supplements. Customers went out more to hunt for these things during the closure, so the category grew. People are getting more concerned about their health as the population grows.

Competitive Landscape

The leading market players in the Global Bone & Joint Health Supplements Market are Bayer AG, Procter & Gamble, Amway, BASF SE, Archer Daniels Midland, Reckitt Benckiser, Pfizer, Vita Life Sciences Ltd, Arazo Nutrition, Nature's Sunshine Products, Inc, Glanbia Plc, Vitawin, Nutramax Laboratories Consumer Care, Inc, Simply Supplements, Love Life Supplements, Now Foods, Bellavita Healthcare Pvt Ltd, Vitaco, Nutravita, Life Extension, Pure Encapsulations, LLC, Herbs Nutriproducts Pvt. Ltd., Millennium Herbal Care, and other prominent players. The Global Bone & Joint Health Supplements Market is highly fragmented with the presence of several manufacturing companies in the country. The market leaders retain their supremacy by spending on research and development, incorporating cutting-edge technology into their goods, and releasing upgraded items for customers. Various tactics, including strategic alliances, agreements, mergers, and partnerships, are used.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Bone & Joint Health Supplements Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Bone & Joint Health Supplements Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC22390

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Type Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Bone & Joint Health Supplements Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising retail sale of nutritional & fortified products
      • 3.2.1.2. Demand is anticipated to increase as vitamin D deficiency becomes more common worldwide
      • 3.2.1.3. Changing customer preferences as a result of increased health awareness
      • 3.2.1.4. Aging population to fuel market expansion
    • 3.2.2. Restraints
      • 3.2.2.1. High R&D investments and high cost of clinical trials
    • 3.2.3. Opportunity
      • 3.2.3.1. The number of people who have osteoporosis is expected to increase, driving demand
      • 3.2.3.2. Food fortification to satisfy consumer awareness about micronutrient deficiencies
    • 3.2.4. Challenges
      • 3.2.4.1. Consumer skepticism associated with nutraceutical products
      • 3.2.4.2. Regulatory influence
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Bone & Joint Health Supplements Market Overview

  • 4.1. Market Size & Forecast, by Value, 2018-2028
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type
      • 4.2.1.1. Vitamin D
      • 4.2.1.2. Vitamin K
      • 4.2.1.3. Calcium
      • 4.2.1.4. Collagen
      • 4.2.1.5. Omega-3 Fatty acids
      • 4.2.1.6. Glucosamine-Chondroitin
      • 4.2.1.7. Others
    • 4.2.2. By Distribution channels
      • 4.2.2.1. Supermarkets/hypermarkets
      • 4.2.2.2. Pharmacies & drug stores
      • 4.2.2.3. Health & beauty stores
      • 4.2.2.4. Others
    • 4.2.3. By Form
      • 4.2.3.1. Tablets
      • 4.2.3.2. Capsules
      • 4.2.3.3. Liquid
      • 4.2.3.4. Powder
      • 4.2.3.5. Others
    • 4.2.4. By Target consumers
      • 4.2.4.1. Infants
      • 4.2.4.2. Children
      • 4.2.4.3. Adults
      • 4.2.4.4. Pregnant woman
      • 4.2.4.5. Elderly people
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia Pacific (APAC)
      • 4.2.5.4. Latin America
      • 4.2.5.5. Middle East and Africa (MEA)

5. North America Bone & Joint Health Supplements Market

    • 5.1.1. Market Size & Forecast, by Value, 2018-2028
    • 5.1.2. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Distribution channels
    • 5.2.3. By Form
    • 5.2.4. By Target consumers
    • 5.2.5. By Country
      • 5.2.5.1. United States
      • 5.2.5.1.1. By Type
      • 5.2.5.1.2. By Distribution channels
      • 5.2.5.1.3. By Form
      • 5.2.5.1.4. By Target consumers
      • 5.2.5.2. Canada
      • 5.2.5.2.1. By Type
      • 5.2.5.2.2. By Distribution channels
      • 5.2.5.2.3. By Form
      • 5.2.5.2.4. By Target consumers

6. Europe Bone & Joint Health Supplements Market

  • 6.1. Market Size & Forecast, by Value, 2018-2028
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Distribution channels
    • 6.2.3. By Form
    • 6.2.4. By Target consumers
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.1.1. By Type
      • 6.2.5.1.2. By Distribution channels
      • 6.2.5.1.3. By Form
      • 6.2.5.1.4. By Target consumers
      • 6.2.5.2. United Kingdom
      • 6.2.5.2.1. By Type
      • 6.2.5.2.2. By Distribution channels
      • 6.2.5.2.3. By Form
      • 6.2.5.2.4. By Target consumers
      • 6.2.5.3. Italy
      • 6.2.5.3.1. By Type
      • 6.2.5.3.2. By Distribution channels
      • 6.2.5.3.3. By Form
      • 6.2.5.3.4. By Target consumers
      • 6.2.5.4. France
      • 6.2.5.4.1. By Type
      • 6.2.5.4.2. By Distribution channels
      • 6.2.5.4.3. By Form
      • 6.2.5.4.4. By Target consumers
      • 6.2.5.5. Spain
      • 6.2.5.5.1. By Type
      • 6.2.5.5.2. By Distribution channels
      • 6.2.5.5.3. By Form
      • 6.2.5.5.4. By Target consumers
      • 6.2.5.6. The Netherlands
      • 6.2.5.6.1. By Type
      • 6.2.5.6.2. By Distribution channels
      • 6.2.5.6.3. By Form
      • 6.2.5.6.4. By Target consumers
      • 6.2.5.7. Belgium
      • 6.2.5.7.1. By Type
      • 6.2.5.7.2. By Distribution channels
      • 6.2.5.7.3. By Form
      • 6.2.5.7.4. By Target consumers
      • 6.2.5.8. NORDIC Countries
      • 6.2.5.8.1. By Type
      • 6.2.5.8.2. By Distribution channels
      • 6.2.5.8.3. By Form
      • 6.2.5.8.4. By Target consumers
      • 6.2.5.9. Rest of Europe
      • 6.2.5.9.1. By Type
      • 6.2.5.9.2. By Distribution channels
      • 6.2.5.9.3. By Form
      • 6.2.5.9.4. By Target consumers

7. Asia Pacific Bone & Joint Health Supplements Market

  • 7.1. Market Size & Forecast, by Value, 2018-2028
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Distribution channels
    • 7.2.3. By Form
    • 7.2.4. By Target consumers
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.1.1. By Type
      • 7.2.5.1.2. By Distribution channels
      • 7.2.5.1.3. By Form
      • 7.2.5.1.4. By Target consumers
      • 7.2.5.2. India
      • 7.2.5.2.1. By Type
      • 7.2.5.2.2. By Distribution channels
      • 7.2.5.2.3. By Form
      • 7.2.5.2.4. By Target consumers
      • 7.2.5.3. Japan
      • 7.2.5.3.1. By Type
      • 7.2.5.3.2. By Distribution channels
      • 7.2.5.3.3. By Form
      • 7.2.5.3.4. By Target consumers
      • 7.2.5.4. South Korea
      • 7.2.5.4.1. By Type
      • 7.2.5.4.2. By Distribution channels
      • 7.2.5.4.3. By Form
      • 7.2.5.4.4. By Target consumers
      • 7.2.5.5. Australia & New Zealand
      • 7.2.5.5.1. By Type
      • 7.2.5.5.2. By Distribution channels
      • 7.2.5.5.3. By Form
      • 7.2.5.5.4. By Target consumers
      • 7.2.5.6. Indonesia
      • 7.2.5.6.1. By Type
      • 7.2.5.6.2. By Distribution channels
      • 7.2.5.6.3. By Form
      • 7.2.5.6.4. By Target consumers
      • 7.2.5.7. Malaysia
      • 7.2.5.7.1. By Type
      • 7.2.5.7.2. By Distribution channels
      • 7.2.5.7.3. By Form
      • 7.2.5.7.4. By Target consumers
      • 7.2.5.8. Singapore
      • 7.2.5.8.1. By Type
      • 7.2.5.8.2. By Distribution channels
      • 7.2.5.8.3. By Form
      • 7.2.5.8.4. By Target consumers
      • 7.2.5.9. Philippines
      • 7.2.5.9.1. By Type
      • 7.2.5.9.2. By Distribution channels
      • 7.2.5.9.3. By Form
      • 7.2.5.9.4. By Target consumers
      • 7.2.5.10. Vietnam
      • 7.2.5.10.1. By Type
      • 7.2.5.10.2. By Distribution channels
      • 7.2.5.10.3. By Form
      • 7.2.5.10.4. By Target consumers
      • 7.2.5.11. Rest of Asia Pacific
      • 7.2.5.11.1. By Type
      • 7.2.5.11.2. By Distribution channels
      • 7.2.5.11.3. By Form
      • 7.2.5.11.4. By Target consumers

8. Latin America Bone & Joint Health Supplements Market

  • 8.1. Market Size & Forecast, by Value, 2018-2028
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Distribution channels
    • 8.2.3. By Form
    • 8.2.4. By Target consumers
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Type
      • 8.2.4.1.2. By Distribution channels
      • 8.2.4.1.3. By Form
      • 8.2.4.1.4. By Target consumers
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Type
      • 8.2.4.2.2. By Distribution channels
      • 8.2.4.2.3. By Form
      • 8.2.4.2.4. By Target consumers
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Type
      • 8.2.4.3.2. By Distribution channels
      • 8.2.4.3.3. By Form
      • 8.2.4.3.4. By Target consumers
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Type
      • 8.2.4.4.2. By Distribution channels
      • 8.2.4.4.3. By Form
      • 8.2.4.4.4. By Target consumers
      • 8.2.4.5. Colombia
      • 8.2.4.5.1. By Type
      • 8.2.4.5.2. By Distribution channels
      • 8.2.4.5.3. By Form
      • 8.2.4.5.4. By Target consumers
      • 8.2.4.6. Rest of Latin America
      • 8.2.4.6.1. By Type
      • 8.2.4.6.2. By Distribution channels
      • 8.2.4.6.3. By Form
      • 8.2.4.6.4. By Target consumers

9. Middle East & Africa Bone & Joint Health Supplements Market

  • 9.1. Market Size & Forecast, by Value, 2018-2028
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Distribution channels
    • 9.2.3. By Form
    • 9.2.4. By Target consumers
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.1.1. By Type
      • 9.2.5.1.2. By Distribution channels
      • 9.2.5.1.3. By Form
      • 9.2.5.1.4. By Target consumers
      • 9.2.5.2. UAE
      • 9.2.5.2.1. By Type
      • 9.2.5.2.2. By Distribution channels
      • 9.2.5.2.3. By Form
      • 9.2.5.2.4. By Target consumers
      • 9.2.5.3. Qatar
      • 9.2.5.3.1. By Type
      • 9.2.5.3.2. By Distribution channels
      • 9.2.5.3.3. By Form
      • 9.2.5.3.4. By Target consumers
      • 9.2.5.4. Kuwait
      • 9.2.5.4.1. By Type
      • 9.2.5.4.2. By Distribution channels
      • 9.2.5.4.3. By Form
      • 9.2.5.4.4. By Target consumers
      • 9.2.5.5. Iran
      • 9.2.5.5.1. By Type
      • 9.2.5.5.2. By Distribution channels
      • 9.2.5.5.3. By Form
      • 9.2.5.5.4. By Target consumers
      • 9.2.5.6. South Africa
      • 9.2.5.6.1. By Type
      • 9.2.5.6.2. By Distribution channels
      • 9.2.5.6.3. By Form
      • 9.2.5.6.4. By Target consumers
      • 9.2.5.7. Nigeria
      • 9.2.5.7.1. By Type
      • 9.2.5.7.2. By Distribution channels
      • 9.2.5.7.3. By Form
      • 9.2.5.7.4. By Target consumers
      • 9.2.5.8. Kenya
      • 9.2.5.8.1. By Type
      • 9.2.5.8.2. By Distribution channels
      • 9.2.5.8.3. By Form
      • 9.2.5.8.4. By Target consumers
      • 9.2.5.9. Egypt
      • 9.2.5.9.1. By Type
      • 9.2.5.9.2. By Distribution channels
      • 9.2.5.9.3. By Form
      • 9.2.5.9.4. By Target consumers
      • 9.2.5.10. Morocco
      • 9.2.5.10.1. By Type
      • 9.2.5.10.2. By Distribution channels
      • 9.2.5.10.3. By Form
      • 9.2.5.10.4. By Target consumers
      • 9.2.5.11. Algeria
      • 9.2.5.11.1. By Type
      • 9.2.5.11.2. By Distribution channels
      • 9.2.5.11.3. By Form
      • 9.2.5.11.4. By Target consumers
      • 9.2.5.12. Rest of Middle East & Africa
      • 9.2.5.12.1. By Type
      • 9.2.5.12.2. By Distribution channels
      • 9.2.5.12.3. By Form
      • 9.2.5.12.4. By Target consumers

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Bone & Joint Health Supplements Company Market Share Analysis, 2021
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

11. Impact of Covid-19 on Global Bone & Joint Health Supplements Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT)

  • 12.1. Bayer AG
  • 12.2. Procter & Gamble
  • 12.3. Amway
  • 12.4. BASF SE
  • 12.5. Archer Daniels Midland
  • 12.6. Reckitt Benckiser
  • 12.7. Pfizer
  • 12.8. Vita Life Sciences Ltd
  • 12.9. Arazo Nutrition
  • 12.10. Nature's Sunshine Products, Inc
  • 12.11. Glanbia Plc
  • 12.12. Vitawin
  • 12.13. Nutramax Laboratories Consumer Care, Inc
  • 12.14. Simply Supplements
  • 12.15. Love Life Supplements
  • 12.16. Now Foods
  • 12.17. Bellavita Healthcare Pvt Ltd
  • 12.18. Vitaco
  • 12.19. Nutravita
  • 12.20. Life Extension
  • 12.21. Pure Encapsulations, LLC
  • 12.22. Herbs Nutriproducts Pvt. Ltd.
  • 12.23. Millennium Herbal Care
  • 12.24. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!